Lpl Financial LLC Aldeyra Therapeutics, Inc. Transaction History
Lpl Financial LLC
- $218 Billion
- Q3 2024
A detailed history of Lpl Financial LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 20,786 shares of ALDX stock, worth $108,710. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,786
Previous 21,336
2.58%
Holding current value
$108,710
Previous $70,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ALDX
# of Institutions
117Shares Held
36.2MCall Options Held
196KPut Options Held
142K-
Perceptive Advisors LLC New York, NY9.28MShares$48.5 Million1.31% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$28.6 Million14.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.76MShares$19.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$18.9 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.88MShares$9.84 Million0.24% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $305M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...